AVDL: Avadel Pharmaceuticals plc filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Regulation FD Disclosure
Stocks in this Quantisnow insightHealth Care
Historical context for AVDL
Across the 8 sessions after earlier AVDL headlines, the stock closed higher 5 times and lower 3 times, with a median move of 0.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | AVDL | SPY |
|---|---|---|---|
| Feb 11, 2026 | Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing | +0.0% | -0.0% |
| Jan 13, 2026 | Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes | -0.1% | -0.2% |
| Dec 18, 2025 | Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 REVITALYZ™ Trial in Idiopathic Hypersomnia | +0.1% | +0.8% |
| Dec 4, 2025 | Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting | -0.0% | +0.1% |
| Dec 2, 2025 | Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting | -0.3% | +0.2% |
| Nov 5, 2025 | FORM 8.1(a) & (b) - Avadel Pharmaceuticals plcand 1 other headline that session | +0.3% | +0.3% |
Quantisnow market dataNASDAQ
AVDL
Avadel Pharmaceuticals plc
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for AVDL
Full AVDL profile on Quantisnow Follow AVDL and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time